PolyNovo Limited (PNV) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for standing by and welcome to the Polynovo First Half FY26 Results Webcast. All participants are in a listen-only mode. There'll be a presentation followed by a question and answer session. If you would like to ask a question, you'll need to press the star key followed by the number one on your telephone keypad. If you would like to ask a question from the webcast, please type it into the Ask a Question box and click Submit. I'd now like to hand the conference over to Mr. Leon Hall, Chairman. Please go ahead. Welcome everyone to Polynovo's Half One Results I'm very pleased to introduce our new CEO. Bruce joined us in December, so it was about 10 weeks into the role. He joins us with a highly impressive background in many executive leadership roles across Australia, APAC and the USA. And he is now engaged in a whole team around the world, including a USA visit, and has met with many professionals and customers. Impressively, Bruce has rapidly built a strong understanding of the business and has identified several areas to enhance many opportunities here at SHU. The board are delighted to have Bruce leading the business. Polynovo is a company already generating strong results. You will see the financial results. Suffice to say, our momentum is very positive. We've completed our new factory and expanded our R&D capability, and we have a highly talented group of professionals driving our growth. Polynovo is focused on growth. We're broadening our global reach, We are adding to our clinical indications. We have a highly innovative Novazorb platform technology that we've only begun to leverage. We have a pipeline of opportunities and importantly our products and technology in clinicians hands provide excellent clinical outcomes. PolyNovo is at an exciting point ...